Dual bronchodilators in bronchiectasis study: A randomised controlled trial
Cartilage or synovial membrane samples were embedded in paraffin, and 5 m sagittal sections were obtained using a Polycut E microtome
The available studies are limited to short-term results, and there are little data on the long-term safety or sustained weight loss after discontinuation of the medication, leading to concerns about possible weight regain [74]
Large-scale cardiovascular safety trials, including the LEADER trial with liraglutide and the SUSTAIN-6 trial with semaglutide, did not report increased blood clot incidence as a primary safety concern
Further, experimental data suggest that the pro-survival action of GLP-1RAs may also be mediated by the Akt-dependent stimulation of the mTORC1/S6K1 pathway, the activation of which is dependent upon the IGF-1R, as observed in rodent islet cells (44)
GHRP-6 must be administered on an empty stomach